Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Wiseman

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Donor cell leukemia: a reviewDaniel H Wiseman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2026
From Molecular Complexity to Personalized Care in Chronic Myelomonocytic LeukemiaDaniel H Wiseman, Kiran Batta
Blood Advances|October 14, 2025
Toward eRASing the challenge of CMML heterogeneityHasse M Addinsell, Daniel H Wiseman
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2017
Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid LeukemiaDaniel H Wiseman, Tim C P Somervaille
Journal of Pediatric Hematology/Oncology|September 25, 2013
In responseDaniel H Wiseman, Jay Rajaram, Robert F Wynn
American Journal of Hematology|February 18, 2011
Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestineDaniel H Wiseman, Mayukh Das, Kay Poulton, et al.
Journal of Pediatric Hematology/Oncology|April 4, 2012
Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1Daniel H Wiseman, Denise K Bonney, Robert F Wynn
Frontiers in Cell and Developmental Biology|March 29, 2021
The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid MalignancyLaura Mosteo, Joanna Storer, Kiran Batta, et al.
Medicinal Research Reviews|November 25, 2014
Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to dateDaniel P Mould, Alison E McGonagle, Daniel H Wiseman, et al.
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2010
Donor cell leukemia: a reviewDaniel H Wiseman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2026
From Molecular Complexity to Personalized Care in Chronic Myelomonocytic LeukemiaDaniel H Wiseman, Kiran Batta
Blood Advances|October 14, 2025
Toward eRASing the challenge of CMML heterogeneityHasse M Addinsell, Daniel H Wiseman
Methods in Molecular Biology (Clifton, N.J.)|July 24, 2017
Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid LeukemiaDaniel H Wiseman, Tim C P Somervaille
Journal of Pediatric Hematology/Oncology|September 25, 2013
In responseDaniel H Wiseman, Jay Rajaram, Robert F Wynn
American Journal of Hematology|February 18, 2011
Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestineDaniel H Wiseman, Mayukh Das, Kay Poulton, et al.
Journal of Pediatric Hematology/Oncology|April 4, 2012
Hemophagocytosis by leukemic megakaryoblasts in acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1Daniel H Wiseman, Denise K Bonney, Robert F Wynn
Frontiers in Cell and Developmental Biology|March 29, 2021
The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid MalignancyLaura Mosteo, Joanna Storer, Kiran Batta, et al.
Medicinal Research Reviews|November 25, 2014
Reversible inhibitors of LSD1 as therapeutic agents in acute myeloid leukemia: clinical significance and progress to dateDaniel P Mould, Alison E McGonagle, Daniel H Wiseman, et al.
Analytical Biochemistry|August 6, 2013
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1James T Lynch, Mark J Cockerill, James R Hitchin, et al.
Pageof 6